Stay updated on SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Sign up to get notified when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.

Latest updates to the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces that NIH agencies are transitioning to use “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check11 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer identifies the site as revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedRevision: v3.7.0 was added to the page. A large portion of the Study Documents and related links, including PDFs and protocol documents, were removed, reducing access to supporting materials for the study.SummaryDifference20%

- Check60 days agoChange DetectedThe page's revision is updated from v3.6.5 to v3.6.6, signaling a minor underlying update to the page or its CMS. No changes to visible content or features are indicated by this revision.SummaryDifference0.1%

- Check81 days agoChange DetectedThe study record was updated to version v3.6.5, indicating a new revision of the page. This typically reflects minor editorial or metadata tweaks rather than substantive changes to the trial details.SummaryDifference0.1%

Stay in the know with updates to SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT-Immunotherapy in Early Lung Cancer: Clinical Trial page.